Conventional Wound Therapy

OTHER3 trials

Sponsors

KeraCure, Integra LifeSciences Corporation, Duke University

Conditions

DiabetesFoot UlcerNeuropathic Diabetic Ulcer - FootPatients Undergoing Hepatopancreatobiliary Surgery

Phase 2

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

KeraCureDiabetes, Foot Ulcer

Start: 2006-01-31End: 2009-09-30Target: 300Updated: 2008-08-26

Unknown Phase

A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers

CompletedNCT01060670

Integra LifeSciences CorporationNeuropathic Diabetic Ulcer - Foot

Start: 2010-04-30End: 2014-06-30Updated: 2016-09-22

Negative Pressure Wound Therapy to Reduce Surgical Site Infection

CompletedNCT01905397

Duke UniversityPatients Undergoing Hepatopancreatobiliary Surgery

Start: 2013-12-18End: 2021-05-26Updated: 2022-12-02

Related Papers

Closed Incision Negative Pressure Therapy to Reduce Surgical Site Infection in High-Risk Gastrointestinal Surgery: A Randomized Controlled Trial

Journal of the American College of Surgeons2023-01-104 citations